Medicines on the FDA drug shortage list, with which forms and strengths are affected, who makes them and when supply is expected back.
240 medicines
-
Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate In shortage 7 products · updated October 16, 2026
Psychiatry
Product Availability Expected supply / notes Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 30mg (NDC 47781-180-01)
AlvogenAvailable —
In shortage · October 16, 2026Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5mg (NDC 47781-174-01)
AlvogenAvailable —
In shortage · October 16, 2026Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 10mg (NDC 47781-176-01)
AlvogenAvailable —
In shortage · October 16, 2026Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 15mg (NDC 47781-178-01)
AlvogenAvailable —
In shortage · October 16, 2026Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 20mg (NDC 47781-179-01)
AlvogenAvailable —
In shortage · October 16, 2026Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0527-1502-37)
Lannett Company, Inc.Available —
In shortage · October 15, 2026Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0527-1505-37)
Lannett Company, Inc.Available —
In shortage · October 15, 2026 -
Ifosfamide In shortage Some forms unavailable 7 products · updated October 16, 2026
Oncology, Pediatric
Product Availability Expected supply / notes IFEX, Injection, 3 g/60 mL (NDC 0338-3993-01)
Baxter HealthcareUnavailable Estimated recovery: November 2026
In shortage · October 16, 2026Ifosfamide, Injection, 50 mg/1 mL (NDC 0143-9531-01)
Hikma Pharmaceuticals USA, Inc.Unavailable Additional lots will be available in the November 2026 timeframe. Product will be made available as it is released.
In shortage · October 14, 2026Ifosfamide, Injection, 50 mg/1 mL (NDC 0143-9530-01)
Hikma Pharmaceuticals USA, Inc.Unavailable Additional lots will be available in the November 2026 timeframe. Product will be made available as it is released.
In shortage · October 14, 2026Ifosfamide, Injection, 1 g/1 (NDC 63323-142-10)
Fresenius Kabi USA, LLCLimited Check wholesalers for inventory
In shortage · October 15, 2026+ 3 more products listed, currently available.
-
Isoleucine, Leucine, Lysine Acetate, Methionine, Phenylalanine, Threonine, Tryptophan, Valine, Alanine, Arginine, Aspartic Acid, Glutamic Acid, Glycine, Histidine, Proline, Serine, Taurine, A In shortage Some forms unavailable 2 products · updated October 16, 2026
Gastroenterology
Product Availability Expected supply / notes Aminosyn-PF 7%, Injection, 0.07 (NDC 0990-4178-03)
Otsuka ICU Medical LLCUnavailable Estimated recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.
In shortage · October 16, 2026Aminosyn-PF 10%, Injection, 0.1 (NDC 0990-4179-05)
Otsuka ICU Medical LLCUnavailable Estimated recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.
In shortage · October 16, 2026 -
Isoleucine, Leucine, Lysine Acetate, Methionine, Phenylalanine, Threonine, Tryptophan, Valine, Alanine, Arginine, Aspartic Acid, Glutamic Acid, Histidine, Proline, Serine, N-Acetyltyrosine, A In shortage 2 products · updated October 16, 2026
Gastroenterology
Product Availability Expected supply / notes Aminosyn II 10% In Plastic Container, Injection, 0.1 (NDC 0990-7172-17)
Otsuka ICU Medical LLCAvailable This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.
In shortage · October 16, 2026Aminosyn II 15% In Plastic Container, Injection, 0.15 (NDC 0990-7171-17)
Otsuka ICU Medical LLCAvailable This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.
In shortage · October 16, 2026 -
Leucine, Lysine, Isoleucine, Valine, Histidine, Phenylalanine, Threonine, Methionine, Tryptophan, Tyrosine, N-Acetyl-Tyrosine, Arginine, Proline, Alanine, Glutamic Acide, Serine, Glycine, Asp In shortage 3 products · updated October 16, 2026
Gastroenterology
Product Availability Expected supply / notes Premasol 10% Sulfite Free in VIAFLEX Plastic Container, Injection, 0.1 (NDC 0338-1130-04)
Baxter HealthcareAvailable —
In shortage · October 16, 2026Premasol 10% Sulfite Free in VIAFLEX Plastic Container, Injection, 0.1 (NDC 0338-1130-03)
Baxter HealthcareAvailable —
In shortage · October 16, 2026Premasol 10% Sulfite Free in VIAFLEX Plastic Container, Injection, 0.1 (NDC 0338-1130-06)
Baxter HealthcareAvailable —
In shortage · October 16, 2026 -
Leucine, Phenylalanine, Lysine Hydrochloride, Methionine, Isoleucine, Valine, Histidine, Threonine, Tryptophan, Alanine, Glycine, Arginine, Proline, Tyrosine, Serine In shortage Some forms unavailable 3 products · updated October 16, 2026
Gastroenterology
Product Availability Expected supply / notes Travasol, Injection, 2.07 g/100 mL; 1.15 g/100 mL; 1.03 g/100 mL; 480 mg/100 mL; 600 mg/100 mL; 730 mg/100 mL; 580 mg/100 mL; 400 mg/100 mL; 560 mg/100 mL; 680 mg/100 mL; 500 mg/100 mL; 420 mg/100 mL; 180 mg/100 mL; 40 mg/100 mL; 580 mg/100 mL (NDC 0338-0644-03)
Baxter HealthcareUnavailable Estimated recovery: December 2026
In shortage · October 16, 2026+ 2 more products listed, currently available.
-
Methylphenidate In shortage 4 products · updated October 16, 2026
Psychiatry
Product Availability Expected supply / notes Methylphenidate, Film, Extended Release, 20 mg (NDC 0574-2420-65)
Noven Pharmaceuticals, Inc.Available Distributed by Padagis US LLC
In shortage · October 16, 2026Methylphenidate, Film, Extended Release, 10 mg (NDC 0574-2410-65)
Noven Pharmaceuticals, Inc.Available Distributed by Padagis US LLC
In shortage · October 16, 2026Methylphenidate, Film, Extended Release, 15 mg (NDC 0574-2415-65)
Noven Pharmaceuticals, Inc.Available Distributed by Padagis US LLC
In shortage · October 16, 2026Methylphenidate, Film, Extended Release, 30 mg (NDC 0574-2430-65)
Noven Pharmaceuticals, Inc.Available Distributed by Padagis US LLC
In shortage · October 16, 2026 -
Technetium Tc 99m Pyrophosphate In shortage Limited supply 1 product · updated October 16, 2026
Medical Imaging
Product Availability Expected supply / notes Technescan PYP, Injection, 11.9 mg/10 mL; 3.2 mg/10 mL (NDC 69945-094-20)
Curium US LLCLimited On allocation
In shortage · October 16, 2026 -
Vigabatrin Being discontinued 1 product · updated October 16, 2026
Neurology
Product Availability Expected supply / notes Vigabatrin, Tablet, 500 mg (NDC 0054-0652-25)
Hikma Pharmaceuticals USA, Inc.The decision to discontinue this drug product was due to a business decision and not due to any reasons of safety or effectiveness.
Being discontinued · October 16, 2026 -
Bupivacaine Hydrochloride and Epinephrine Bitartrate In shortage Some forms unavailable 8 products · updated October 15, 2026
Anesthesia
Product Availability Expected supply / notes Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-462-31)
Fresenius Kabi USA, LLCUnavailable Estimated recovery: TBD
In shortage · October 15, 2026Sensorcaine, Injection, 2.5 mg/1 mL; .005 mg/1 mL (NDC 63323-461-57)
Fresenius Kabi USA, LLCUnavailable Next release November 2026. Check wholesalers for inventory.
In shortage · October 15, 2026Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-463-57)
Fresenius Kabi USA, LLCUnavailable Next release October 2026. Check wholesalers for inventory.
In shortage · October 15, 2026+ 5 more products listed, currently available.
-
Conivaptan Hydrochloride In shortage Some forms unavailable 1 product · updated October 15, 2026
Cardiovascular
Product Availability Expected supply / notes Vaprisol Dextrose In Plastic Container, Injection, 20 mg/100 mL (NDC 66220-160-10)
Cumberland Pharmaceuticals Inc.Unavailable Estimated recovery: TBD
In shortage · October 15, 2026 -
Desmopressin Acetate In shortage Some forms unavailable 4 products · updated October 15, 2026
Hematology
Product Availability Expected supply / notes Stimate, Spray, 1.5 mg/1 mL (NDC 0053-6871-00)
FerringUnavailable Estimated recovery: TBD
In shortage · May 1, 2026Ddavp, Spray, .1 ug/1 mL (NDC 55566-2500-0)
FerringUnavailable Estimated recovery: TBD
In shortage · May 1, 2026Desmopressin Acetate, Spray, 10 ug/.1 mL (NDC 69918-501-05)
FerringUnavailable Estimated recovery: TBD
In shortage · May 1, 2026Desmopressin Acetate (needs No Refrigeration), Spray, 10 ug (NDC 60505-0815-0)
Apotex Corp.Limited Replenishment expected mid to late November 2026
In shortage · October 15, 2026 -
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate In shortage Some forms unavailable 7 products · updated October 15, 2026
Psychiatry
Product Availability Expected supply / notes Adderall, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 57844-112-01)
Teva Pharmaceuticals USA, Inc.Unavailable Estimated recovery: November 2026
In shortage · October 15, 2026+ 6 more products listed, currently available.
-
Lidocaine Hydrochloride,epinephrine Bitartrate In shortage Some forms unavailable 10 products · updated October 15, 2026
Anesthesia, Pediatric
Product Availability Expected supply / notes Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-17)
Fresenius Kabi USA, LLCUnavailable Next release November 2026. Check wholesalers for inventory.
In shortage · October 15, 2026Xylocaine, Injection, .005 mg/1 mL; 5 mg/1 mL (NDC 63323-481-57)
Fresenius Kabi USA, LLCUnavailable Next release October 2026. Check wholesalers for inventory.
In shortage · October 15, 2026Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL (NDC 63323-489-27)
Fresenius Kabi USA, LLCUnavailable Next release October 2026. Check wholesalers for inventory.
In shortage · October 15, 2026+ 7 more products listed, currently available.
-
Methotrexate Sodium In shortage 2 products · updated October 15, 2026
Rheumatology, Oncology
Product Availability Expected supply / notes Methotrexate Preservative Free, Injection, 1 g (NDC 63323-122-50)
Fresenius Kabi USA, LLCAvailable Check wholesaler for inventory
In shortage · October 15, 2026Methotrexate Sodium, Injection, 25 mg/1 mL (NDC 63323-123-10)
Fresenius Kabi USA, LLCAvailable Check wholesaler for inventory
In shortage · October 15, 2026 -
Propranolol Hydrochloride In shortage Some forms unavailable 2 products · updated October 15, 2026
Cardiovascular
Product Availability Expected supply / notes Propranolol Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-604-01)
Fresenius Kabi USA, LLCUnavailable Next release: November 2026. Check wholesalers for inventory.
In shortage · October 15, 2026Propranolol Hydrochloride, Injection, 1 mg/1 mL (NDC 0143-9872-10)
Hikma Pharmaceuticals USA, Inc.Unavailable Estimated recovery: TBD
In shortage · October 14, 2026 -
Riluzole In shortage Some forms unavailable 4 products · updated October 15, 2026
Neurology
Product Availability Expected supply / notes Tiglutik, Oral Suspension, 50 mg/10 mL (NDC 70726-0303-1)
EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.)Unavailable Estimated recovery: TBD
In shortage · October 15, 2026+ 3 more products listed, currently available.
-
Streptozocin Powder, For In shortage Some forms unavailable 2 products · updated October 15, 2026
Oncology
Product Availability Expected supply / notes Zanosar, Powder, For Solution, 100 mg/1 mL (NDC 0703-4636-01)
Teva Pharmaceuticals USA, Inc.Unavailable Estimated recovery: TBD
In shortage · October 15, 2026+ 1 more product listed, currently available.
-
Valproate Sodium In shortage Some forms unavailable 2 products · updated October 15, 2026
Neurology
Product Availability Expected supply / notes Valproate Sodium, Injection, 100 mg/1 mL (NDC 63323-494-05)
Fresenius Kabi USA, LLCUnavailable Next release November 2026. Check wholesalers for inventory.
In shortage · October 15, 2026+ 1 more product listed, currently available.
-
Cefotaxime In shortage Some forms unavailable 6 products · updated October 14, 2026
Anti-Infective, Pediatric
Product Availability Expected supply / notes Cefotaxime Sodium, Powder, for Solution, 2 g (NDC 0143-9933-25)
Hikma Pharmaceuticals USA, Inc.Unavailable Estimated recovery: TBD
In shortage · October 14, 2026Cefotaxime Sodium, Powder, for Solution, 10 g (NDC 0143-9935-01)
Hikma Pharmaceuticals USA, Inc.Unavailable Estimated recovery: TBD
In shortage · October 14, 2026Cefotaxime Sodium, Powder, for Solution, 500 mg (NDC 0143-9930-10)
Hikma Pharmaceuticals USA, Inc.Unavailable Estimated recovery: TBD
In shortage · October 14, 2026Cefotaxime Sodium, Powder, for Solution, 1 g (NDC 0143-9931-25)
Hikma Pharmaceuticals USA, Inc.Unavailable Estimated recovery: TBD
In shortage · October 14, 2026+ 2 more products listed, currently available.
-
Everolimus Being discontinued 15 products · updated October 14, 2026
Transplant
Product Availability Expected supply / notes Everolimus, Tablet, 1 mg (NDC 49884-283-02)
Par Health, USA LLCA business decision was made to withdraw from sale.
Being discontinued · October 14, 2026Everolimus, Tablet, .5 mg (NDC 49884-159-02)
Par Health, USA LLCA business decision was made to withdraw from sale.
Being discontinued · October 14, 2026Everolimus, Tablet, .25 mg (NDC 49884-158-02)
Par Health, USA LLCA business decision was made to withdraw from sale.
Being discontinued · October 14, 2026Everolimus, Tablet, .75 mg (NDC 49884-160-02)
Par Health, USA LLCA business decision was made to withdraw from sale.
Being discontinued · October 14, 2026Everolimus, Tablet, 10 mg (NDC 0093-7769-24)
Teva Pharmaceuticals USA, Inc.Discontinuation of the manufacture of the drug
Being discontinued · March 2, 2026Everolimus, Tablet, 7.5 mg (NDC 0093-7768-24)
Teva Pharmaceuticals USA, Inc.Discontinuation of the manufacture of the drug
Being discontinued · March 2, 2026Everolimus, Tablet, 5 mg (NDC 0093-7767-24)
Teva Pharmaceuticals USA, Inc.Discontinuation of the manufacture of the drug
Being discontinued · March 2, 2026Everolimus, Tablet, 2.5 mg (NDC 0093-7766-24)
Teva Pharmaceuticals USA, Inc.Discontinuation of the manufacture of the drug
Being discontinued · March 2, 2026Everolimus, Tablet, 2.5 mg (NDC 49884-119-91)
Endo Pharmaceuticals, Inc.Discontinuation of the manufacture of the drug
Being discontinued · January 6, 2026Everolimus, Tablet, 5 mg (NDC 49884-125-91)
Endo Pharmaceuticals, Inc.Discontinuation of the manufacture of the drug
Being discontinued · January 6, 2026Everolimus, Tablet, 10 mg (NDC 49884-128-91)
Endo Pharmaceuticals, Inc.Discontinuation of the manufacture of the drug
Being discontinued · January 6, 2026Everolimus, Tablet, 7.5 mg (NDC 49884-127-91)
Endo Pharmaceuticals, Inc.Discontinuation of the manufacture of the drug
Being discontinued · January 6, 2026Everolimus, Tablet, 2 mg (NDC 0378-0005-85)
Mylan Pharmaceuticals Inc., a Viatris CompanyDiscontinuation of the manufacture of the drug
Being discontinued · November 3, 2025Everolimus, Tablet, 5 mg (NDC 0378-0007-85)
Mylan Pharmaceuticals Inc., a Viatris CompanyDiscontinuation of the manufacture of the drug
Being discontinued · November 3, 2025Everolimus, Tablet, 3 mg (NDC 0378-0006-85)
Mylan Pharmaceuticals Inc., a Viatris CompanyDiscontinuation of the manufacture of the drug
Being discontinued · November 3, 2025 -
Liraglutide In shortage Limited supply 11 products · updated October 14, 2026
Endocrinology/Metabolism
Product Availability Expected supply / notes Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-12)
Novo Nordisk, Inc.Limited Estimated shortage duration: TBD
In shortage · September 22, 2026Saxenda, Injection, 6 mg/1 mL (NDC 0169-2800-15)
Novo Nordisk, Inc.Limited Product will be available until discontinuation in January 2027
In shortage · September 22, 2026Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-13)
Novo Nordisk, Inc.Limited Estimated shortage duration: TBD
In shortage · September 22, 2026Saxenda, Injection, 6 mg/1 mL (NDC 0169-2800-15)
Novo Nordisk, Inc.Product will be available until discontinuation in January 2027; Discontinuation of the manufacture of the drug
Being discontinued · August 25, 2026Liraglutide, Injection, 6 mg/1 mL (NDC 0480-7250-46)
Teva Pharmaceuticals USA, Inc.Discontinuation of the manufacture of the drug
Being discontinued · May 14, 2026+ 6 more products listed, currently available.
-
Midazolam In shortage 5 products · updated October 14, 2026
Anesthesia, Neurology
Product Availability Expected supply / notes Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6057-25)
Hikma Pharmaceuticals USA, Inc.Available Additional lots are scheduled to be manufactured. Product will be made available as it is released.
In shortage · October 14, 2026Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 0641-6061-25)
Hikma Pharmaceuticals USA, Inc.Available Additional lots are scheduled to be manufactured. Product will be made available as it is released.
In shortage · October 14, 2026Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6059-01)
Hikma Pharmaceuticals USA, Inc.Available Additional lots are scheduled to be manufactured. Product will be made available as it is released.
In shortage · October 14, 2026Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6056-10)
Hikma Pharmaceuticals USA, Inc.Available Additional lots are scheduled to be manufactured. Product will be made available as it is released.
In shortage · October 14, 2026Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 0641-6060-10)
Hikma Pharmaceuticals USA, Inc.Available Additional lots are scheduled to be manufactured. Product will be made available as it is released.
In shortage · October 14, 2026 -
Promethazine Hydrochloride In shortage Some forms unavailable 10 products · updated October 14, 2026
Analgesia/Addiction, Gastroenterology, Pediatric, Pulmonary/Allergy, Other
Product Availability Expected supply / notes Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-1495-35)
Hikma Pharmaceuticals USA, Inc.Unavailable Additional lots will be available in the November 2026 timeframe. Product will be made available as it is released.
In shortage · October 14, 2026Phenergan, Injection, 50 mg/1 mL (NDC 0641-6085-25)
Hikma Pharmaceuticals USA, Inc.Unavailable Estimated recovery: TBD
In shortage · October 14, 2026Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 0641-0929-25)
Hikma Pharmaceuticals USA, Inc.Unavailable Estimated recovery: TBD
In shortage · October 14, 2026Phenergan, Injection, 25 mg/1 mL (NDC 0641-6084-25)
Hikma Pharmaceuticals USA, Inc.Unavailable Estimated recovery: TBD
In shortage · October 14, 2026Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 39822-5550-6)
XGen Pharmaceuticals DJB, Inc.Unavailable Estimated recovery: TBD
In shortage · September 22, 2026+ 5 more products listed, currently available.
-
Quinapril In shortage Some forms unavailable 11 products · updated October 13, 2026
Cardiovascular
Product Availability Expected supply / notes Quinapril Hydrochloride, Tablet, 20 mg (NDC 68180-558-09)
Lupin Pharmaceuticals, Inc.Unavailable Estimated recovery: TBD
In shortage · October 13, 2026Quinapril Hydrochloride, Tablet, 40 mg (NDC 68180-554-09)
Lupin Pharmaceuticals, Inc.Unavailable Estimated recovery: TBD
In shortage · October 13, 2026Quinapril Hydrochloride, Tablet, 10 mg (NDC 68180-557-09)
Lupin Pharmaceuticals, Inc.Unavailable Estimated recovery: TBD
In shortage · October 13, 2026Quinapril Hydrochloride, Tablet, 5 mg (NDC 43547-410-09)
Solco Healthcare US, LLCUnavailable Not available. Long-term backorder for all NDCs. No estimated release date at this time.
In shortage · June 29, 2026Quinapril Hydrochloride, Tablet, 20 mg (NDC 43547-412-09)
Solco Healthcare US, LLCUnavailable Not available. Long-term backorder for all NDCs. No estimated release date at this time.
In shortage · June 29, 2026Quinapril Hydrochloride, Tablet, 40 mg (NDC 43547-413-09)
Solco Healthcare US, LLCUnavailable Not available. Long-term backorder for all NDCs. No estimated release date at this time.
In shortage · June 29, 2026Quinapril Hydrochloride, Tablet, 10 mg (NDC 43547-411-09)
Solco Healthcare US, LLCUnavailable Not available. Long-term backorder for all NDCs. No estimated release date at this time.
In shortage · June 29, 2026+ 4 more products listed, currently available.
-
Quinapril Hydrochloride In shortage Some forms unavailable 5 products · updated October 13, 2026
Cardiovascular
Product Availability Expected supply / notes Quinapril Hydrochloride, Tablet, 5 mg (NDC 68180-556-09)
Lupin Pharmaceuticals, Inc.Unavailable Estimated recovery: TBD
In shortage · October 13, 2026Quinapril Hydrochloride, Tablet, 10 mg (NDC 65862-618-90)
Aurobindo Pharma USAUnavailable Discontinuation of the manufacture of the drug
In shortage · October 2, 2026Quinapril Hydrochloride, Tablet, 5 mg (NDC 65862-617-90)
Aurobindo Pharma USAUnavailable Discontinuation of the manufacture of the drug
In shortage · October 2, 2026Quinapril Hydrochloride, Tablet, 40 mg (NDC 65862-620-90)
Aurobindo Pharma USAUnavailable Discontinuation of the manufacture of the drug
In shortage · October 2, 2026Quinapril Hydrochloride, Tablet, 10 mg (NDC 65862-618-90)
Aurobindo Pharma USAUnavailable Discontinuation of the manufacture of the drug
In shortage · October 2, 2026 -
Lidocaine Hydrochloride Anhydrous In shortage Some forms unavailable 1 product · updated October 8, 2026
Anesthesia
Product Availability Expected supply / notes Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 65282-1605-1)
Spectra Medical Devices, LLCUnavailable Estimated recovery: TBD
In shortage · October 8, 2026 -
Felodipine Being discontinued 6 products · updated October 7, 2026
Cardiovascular
Product Availability Expected supply / notes Felodipine, Tablet, Extended Release, 2.5 mg (NDC 0603-3581-21)
Par Health, USA LLCDiscontinuation in the manufacturing of the drug product
Being discontinued · October 7, 2026Felodipine, Tablet, Extended Release, 2.5 mg (NDC 0603-3581-28)
Par Health, USA LLCDiscontinuation in the manufacturing of the drug product
Being discontinued · October 7, 2026Felodipine, Tablet, Extended Release, 5 mg (NDC 0603-3582-21)
Par Health, USA LLCDiscontinuation in the manufacturing of the drug product
Being discontinued · October 7, 2026Felodipine, Tablet, Extended Release, 5 mg (NDC 0603-3582-28)
Par Health, USA LLCDiscontinuation in the manufacturing of the drug product
Being discontinued · October 7, 2026Felodipine, Tablet, Film Coated, Extended Release, 10 mg (NDC 0603-3583-21)
Par Health, USA LLCDiscontinuation in the manufacturing of the drug product
Being discontinued · October 7, 2026Felodipine, Tablet, Film Coated, Extended Release, 10 mg (NDC 0603-3583-28)
Par Health, USA LLCDiscontinuation in the manufacturing of the drug product
Being discontinued · October 7, 2026 -
Fluocinonide Being discontinued 3 products · updated October 2, 2026
Dermatology
Product Availability Expected supply / notes Fluocinonide, Ointment, .5 mg/1 g (NDC 0093-0264-92)
Teva Pharmaceuticals USA, Inc.Discontinuation of the manufacture of the drug
Being discontinued · October 2, 2026Fluocinonide, Ointment, .5 mg/1 g (NDC 0093-0264-30)
Teva Pharmaceuticals USA, Inc.Discontinuation of the manufacture of the drug
Being discontinued · October 2, 2026Fluocinonide, Ointment, .5 mg/1 g (NDC 0093-0264-15)
Teva Pharmaceuticals USA, Inc.Discontinuation of the manufacture of the drug
Being discontinued · October 2, 2026 -
Quinapril and Hydrochlorothiazide In shortage 3 products · updated October 2, 2026
Cardiovascular
Product Availability Expected supply / notes Quinapril/Hydrochlorothiazide, Tablet, 12.5 mg; 20 mg (NDC 62135-668-90)
Chartwell Molecular Holdings LLCAvailable —
In shortage · October 2, 2026Quinapril/Hydrochlorothiazide, Tablet, 12.5 mg; 10 mg (NDC 62135-667-90)
Chartwell Molecular Holdings LLCAvailable —
In shortage · October 2, 2026Quinapril/Hydrochlorothiazide, Tablet, 25 mg; 20 mg (NDC 62135-669-90)
Chartwell Molecular Holdings LLCAvailable —
In shortage · October 2, 2026
Reading the list: a medicine stays on the FDA list while any of its products is short. "Available" next to a product means that particular strength or pack can currently be ordered. If your pharmacy cannot fill a prescription, ask the pharmacist or prescriber about another strength, form or an alternative — do not ration or stop a medicine on your own.
Source: FDA Drug Shortages Database, via openFDA. Updated here twice a day; last update October 31, 2026 14:40. openFDA data are not validated for clinical use — confirm with the FDA source or your pharmacist.